UO1 CA111294/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	1
2009	1
2011	4
2012	6
2013	6
2014	6
2015	5
2016	2
2024	0

1

Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

Rachagani S, Macha MA, Heimann N, Seshacharyulu P, Haridas D, Chugh S, Batra SK. Rachagani S, et al. Adv Drug Deliv Rev. 2015 Jan;81:16-33. doi: 10.1016/j.addr.2014.10.020. Epub 2014 Oct 23. Adv Drug Deliv Rev. 2015. PMID: 25453266 Free PMC article. Review.

2

Mucin-based targeted pancreatic cancer therapy.

Torres MP, Chakraborty S, Souchek J, Batra SK. Torres MP, et al. Curr Pharm Des. 2012;18(17):2472-81. doi: 10.2174/13816128112092472. Curr Pharm Des. 2012. PMID: 22372499 Free PMC article. Review.

3

Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Mimeault M, Batra SK. Mimeault M, et al. Mol Aspects Med. 2014 Oct;39:3-32. doi: 10.1016/j.mam.2013.08.001. Epub 2013 Aug 29. Mol Aspects Med. 2014. PMID: 23994756 Free PMC article. Review.

4

Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.

Momi N, Kaur S, Ponnusamy MP, Kumar S, Wittel UA, Batra SK. Momi N, et al. Carcinogenesis. 2012 Sep;33(9):1617-28. doi: 10.1093/carcin/bgs186. Epub 2012 May 23. Carcinogenesis. 2012. PMID: 22623649 Free PMC article. Review.

5

Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.

Mimeault M, Batra SK. Mimeault M, et al. Drug Discov Today. 2013 Feb;18(3-4):128-40. doi: 10.1016/j.drudis.2012.08.002. Epub 2012 Aug 10. Drug Discov Today. 2013. PMID: 22903142 Free PMC article. Review.

6

Prospects of miRNA-based therapy for pancreatic cancer.

Pai P, Rachagani S, Are C, Batra SK. Pai P, et al. Curr Drug Targets. 2013 Sep;14(10):1101-9. doi: 10.2174/13894501113149990181. Curr Drug Targets. 2013. PMID: 23834151 Free PMC article. Review.

7

Current status of mucins in the diagnosis and therapy of cancer.

Rachagani S, Torres MP, Moniaux N, Batra SK. Rachagani S, et al. Biofactors. 2009 Nov-Dec;35(6):509-27. doi: 10.1002/biof.64. Biofactors. 2009. PMID: 19904814 Free PMC article. Review.

8

Targeting the EGFR signaling pathway in cancer therapy.

Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK. Seshacharyulu P, et al. Expert Opin Ther Targets. 2012 Jan;16(1):15-31. doi: 10.1517/14728222.2011.648617. Epub 2012 Jan 12. Expert Opin Ther Targets. 2012. PMID: 22239438 Free PMC article. Review.

9

Pathobiological implications of MUC16 expression in pancreatic cancer.

Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, Wittel UA, Hollingsworth MA, Batra SK. Haridas D, et al. PLoS One. 2011;6(10):e26839. doi: 10.1371/journal.pone.0026839. Epub 2011 Oct 31. PLoS One. 2011. PMID: 22066010 Free PMC article.

10

The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.

Pai P, Rachagani S, Lakshmanan I, Macha MA, Sheinin Y, Smith LM, Ponnusamy MP, Batra SK. Pai P, et al. Mol Oncol. 2016 Feb;10(2):224-39. doi: 10.1016/j.molonc.2015.10.005. Epub 2015 Oct 19. Mol Oncol. 2016. PMID: 26526617 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year